Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02876224
What this trial is testing

Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 51
Early research (Phase 1)Study completedNCT04427917
What this trial is testing

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

Who this might be right for
Healthy
Pfizer 8
Testing effectiveness (Phase 2)WithdrawnNCT06622668
What this trial is testing

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Who this might be right for
Lung DiseasePulmonary DiseaseAATD+2 more
Intellia Therapeutics
Testing effectiveness (Phase 2)Study completedNCT03685708
What this trial is testing

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
HepatitisSafety and Tolerability
National Heart, Lung, and Blood Institute (NHLBI) 78
Post-approval studies (Phase 4)Study completedNCT00724620
What this trial is testing

PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Schering-Plough 103
Early research (Phase 1)Study completedNCT02988440
What this trial is testing

Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT01684410
What this trial is testing

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Grifols Therapeutics LLC 30
Early research (Phase 1)UnknownNCT04149691
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

Who this might be right for
Gastric CancerBladder CancerSquamous Non-small Cell Lung Cancer+4 more
Celon Pharma SA 42
Not applicableStudy completedNCT07293091
What this trial is testing

Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages

Who this might be right for
Gastrointestinal TolerabilityAppetiteAmino Acids
Midwest Center for Metabolic and Cardiovascular Research 30
Testing effectiveness (Phase 2)Study completedNCT02230670
What this trial is testing

IDN-6556 in Subjects With Liver Cirrhosis

Who this might be right for
Liver CirrhosisHepatic Cirrhosis
Conatus Pharmaceuticals Inc. 87
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Early research (Phase 1)Study completedNCT04488705
What this trial is testing

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Who this might be right for
Healthy
Enterprise Therapeutics Ltd 80
Testing effectiveness (Phase 2)Study completedNCT02854605
What this trial is testing

Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Gilead Sciences 140
Early research (Phase 1)Study completedNCT01509846
What this trial is testing

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Who this might be right for
Shigellosis
PATH 82
Early research (Phase 1)Ended earlyNCT05977322
What this trial is testing

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastroesophageal AdenocarcinomaGlioblastoma Multiforme
Novartis Pharmaceuticals 24
Early research (Phase 1)Looking for participantsNCT07632573
What this trial is testing

A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

Who this might be right for
Ulcerative Colitis (UC)Ulcerative Colitis (Disorder)Ulcerative Colitis Acute+2 more
Benethera (Shaoxing) Biotechnology Co., Ltd. 68
Large-scale testing (Phase 3)Study completedNCT01405937
What this trial is testing

Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 51
Early research (Phase 1)Study completedNCT06037577
What this trial is testing

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)Systemic Sclerosis (SSc)
ChemomAb Ltd. 8
Early research (Phase 1)Looking for participantsNCT06687941
What this trial is testing

Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung+1 more
Aptamer Sciences, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00561353
What this trial is testing

TMC435350 Administered With or Without Standard of Care Therapy in Participants With Genotype 1 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
Tibotec Pharmaceuticals, Ireland 121
Next Page